MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AKBA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Akebia Therapeutics (AKBA) Ownership - Who owns Akebia Therapeutics?

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
776.87M
P/E Ratio
N/A
Total Cash
137.31M
Projected Growth
N/A
Total Debt
53.36M
Revenue
203.73M
Risk (Beta)
-0.15
Dividend Yield
N/A
Total Cash/Share
0.52
Total Debt/Equity
N/A
Revenue/Share
0.86 USD as % of share price

Fundamentals

AKBA
Capitalization
777M
P/E Ratio
N/A
Risk (Beta)
-0.15
Dividend Yield
N/A
Total Cash
137M
Total Cash/Share
0.52
Total Debt
53.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.86%
Revenue
204M
ROE
N/A
Book Value
29.2M
P/B Ratio
26.60
Cash Flow
N/A
Earnings
-0.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.98
Current Revenue Per Employee
345149.16
Dividends Per Share - Security
N/A
EBITDA
11M
Float
N/A
Float - Current
N/A
Gross Income Margin
84.12
Revenue To Assets
-12.90
Shares Held By Institutions
518M
Shares Outstanding - Current
265M
Total Liabilities
316M
Total Volume MTD
N/A
Value
-1
Gain YTD
54.211
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AKBA
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For AKBA
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AKBA showed earnings on August 07, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com